**Core Concept**
The use of combined oral contraceptive pills (COCs) is contraindicated in certain conditions due to the increased risk of thromboembolic events. COCs contain estrogen and progesterone, which can affect blood clotting and increase the risk of venous thromboembolism.

**Why the Correct Answer is Right**
The correct answer is a condition that significantly increases the risk of venous thromboembolism, making it an absolute contraindication for COC use. This condition involves a hypercoagulable state, where the blood has a tendency to clot more easily, increasing the risk of thromboembolic events. The presence of this condition would make the use of COCs particularly risky, as it would further increase the risk of blood clots.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because, although it is a risk factor for venous thromboembolism, it is not an absolute contraindication for COC use. COCs may still be used with caution and under close monitoring in patients with this condition.

**Option B:** This option is incorrect because it is not a direct contraindication for COC use. While COCs may not be the best choice for patients with this condition, they are not absolutely contraindicated.

**Option C:** This option is incorrect because it is not a contraindication for COC use. In fact, COCs are often used to manage this condition by regulating menstrual cycles and reducing menstrual cramp symptoms.

**Clinical Pearl / High-Yield Fact**
Patients with a history of deep vein thrombosis (DVT) or pulmonary embolism (PE) are at increased risk of recurrent thromboembolic events. COCs are contraindicated in these patients due to the increased risk of thromboembolism.

**Correct Answer: D. History of DVT or PE. History of deep vein thrombosis or pulmonary embolism.**